BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31277738)

  • 1. High-Dose Chemotherapy and Autologous Stem Cell Transplant.
    Adra N; Abonour R
    Urol Clin North Am; 2019 Aug; 46(3):439-448. PubMed ID: 31277738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose chemotherapy with autologous stem cell transplantation in relapsed or refractory germ cell tumours: outcomes and prognostic variables in a case series of 17 patients.
    Lewin J; Dickinson M; Voskoboynik M; Collins M; Ritchie D; Toner G
    Intern Med J; 2014 Aug; 44(8):771-8. PubMed ID: 24893627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk-Stratified Initial Salvage Therapy for Relapsed or Refractory Metastatic Germ Cell Tumors.
    Narayan V; Gunnarsson O; Hwang WT; Squillante CM; Nathanson KL; Stadtmauer EA; Vaughn DJ
    Clin Genitourin Cancer; 2016 Dec; 14(6):524-529. PubMed ID: 27083130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promising novel therapies for relapsed and refractory testicular germ cell tumors.
    Kozakova K; Mego M; Cheng L; Chovanec M
    Expert Rev Anticancer Ther; 2021 Jan; 21(1):53-69. PubMed ID: 33138660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous Stem-Cell Transplantation Outcomes for Relapsed Metastatic Germ-Cell Tumors in the Modern Era.
    Hamid AA; Markt SC; Vicier C; McDermott K; Richardson P; Ho VT; Sweeney CJ
    Clin Genitourin Cancer; 2019 Feb; 17(1):58-64.e1. PubMed ID: 30309761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of one, two and three doses of high-dose chemotherapy with autologous transplantation in the treatment of high-risk or relapsed testicular cancer: a systematic review.
    Bin Riaz I; Umar M; Zahid U; Husnain M; Iftikhar A; McBride A; Bilal J; Javed A; Akbar S; Singh P; Ali Z; Sipra QUAR; Gondal FR; Ahman F; Anwer F
    Bone Marrow Transplant; 2018 Oct; 53(10):1242-1254. PubMed ID: 29703969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer - a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA).
    Haugnes HS; Laurell A; Stierner U; Bremnes RM; Dahl O; Cavallin-Ståhl E; Cohn-Cedermark G
    Acta Oncol; 2012 Feb; 51(2):168-76. PubMed ID: 22175254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Salvage High-Dose Chemotherapy in Relapsed Male Germ Cell Tumors.
    Oing C; Lorch A
    Oncol Res Treat; 2018; 41(6):365-369. PubMed ID: 29843143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Roisin M. Connolly, John A. McCaffrey. High-dose chemotherapy plus stem cell transplantation in advanced germ cell cancer: a review. Eur Urol 2009;56:57-64.
    Necchi A; Nicolai N; Salvioni R
    Eur Urol; 2010 Jan; 57(1):e5-6. PubMed ID: 19818550
    [No Abstract]   [Full Text] [Related]  

  • 10. Salvage high-dose chemotherapy for germ cell tumors.
    Feldman DR; Powles T
    Urol Oncol; 2015 Aug; 33(8):355-62. PubMed ID: 25837842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage therapy with high-dose chemotherapy and peripheral blood stem cell transplant in patients with primary mediastinal nonseminomatous germ cell tumors.
    Suleiman Y; Siddiqui BK; Brames MJ; Abonour R; Einhorn LH
    Biol Blood Marrow Transplant; 2013 Jan; 19(1):161-3. PubMed ID: 22892555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors.
    Einhorn LH; Williams SD; Chamness A; Brames MJ; Perkins SM; Abonour R
    N Engl J Med; 2007 Jul; 357(4):340-8. PubMed ID: 17652649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Dose Chemotherapy With Autologous Stem Cell Transplant for Patients With Advanced Germ Cell Tumors: Real-World Evidence From a Tertiary Cancer Center in Brazil.
    Polho GB; Cunha MT; Coelho MHM; Almeida-Silva J; Hidalgo Filho CM; Xavier EM; Crusoe NS; Atanazio MJ; de Vasconcellos VF; Horita VN; Freitas GF; Muniz DQ; Rocha V; Mota JM
    Clin Genitourin Cancer; 2024 Jun; 22(3):102083. PubMed ID: 38658209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose chemotherapy plus stem cell transplantation in advanced germ cell cancer: a review.
    Connolly RM; McCaffrey JA
    Eur Urol; 2009 Jul; 56(1):57-64. PubMed ID: 19303697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should high dose chemotherapy with, or without, autologous bone marrow transplant be included in the primary treatment of testicular cancer? Round table discussion.
    Grigor KM; Schmoll HJ
    Eur Urol; 1993; 23(1):240-4. PubMed ID: 8386655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive and timely chemotherapy, the key of success in testicular cancer.
    Fléchon A; Culine S; Droz JP
    Crit Rev Oncol Hematol; 2001 Jan; 37(1):35-46. PubMed ID: 11164717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose chemotherapy plus peripheral blood stem cell transplantation for patients with relapsed germ cell tumors and active brain metastases.
    Kalra M; Adra N; Hanna N; Abonour R; Einhorn LH
    Cancer; 2020 Mar; 126(6):1202-1207. PubMed ID: 31743434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Dose Chemotherapy in Relapsed or Refractory Metastatic Germ-Cell Cancer: The Scotland Experience.
    Tan YY; Al-Bubseeree B; Irvine D; MacDonald G; McQuaker G; Parker A; Waterston A; White J
    Clin Genitourin Cancer; 2019 Apr; 17(2):125-131. PubMed ID: 30563754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of second-line chemotherapy and prognostic models for disseminated germ cell tumors.
    Voss MH; Feldman DR; Bosl GJ; Motzer RJ
    Hematol Oncol Clin North Am; 2011 Jun; 25(3):557-76, viii -ix. PubMed ID: 21570609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the optimal high-dose treatment following autologous stem cell transplantation in relapsed or refractory germ cell cancer: a retrospective comparison of high-dose ICE and high-dose CE.
    Yildiz B; Pinar Aral I; Balyemez U; Esin E; Erturk I; Acar R; Karadurmus N
    J BUON; 2020; 25(2):1136-1140. PubMed ID: 32521917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.